The drug, known as bepridil, is used to treat a heart condition called Angina. The team’s leader, Texas A&M Department of Chemistry Professor Wenshe Liu, says it received FDA approval back in the 1990s. If bepridil eventually receives authorization to treat COVID-19, it would be only the second FDA-approved treatment for the virus along with Remdesivir.
While first-dose shots continue to be administered inside the Brazos Center for the first half of the week, a drive-thru will be set up in the back parking lot for second doses. Brazos County COVID-19 Vaccination Task Force Chief Jim Stewart says this is to avoid confusion between people coming in for different doses.